DONGKOO BIO & PHARMA CO., LTD. – Trademark Portfolio

Entity Type: 03

DONGKOO BIO & PHARMA CO., LTD. holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 2 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include CELL BLOOM.

B-14F, M State Building,

114, Beobwon-ro, Songpa-gu Seoul 05854

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

DONGKOO BIO & PHARMA CO., LTD.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (2 filings)

Surgical, medical, dental and veterinary apparatus and instruments

3
Cosmetics & Cleaning (1 filing)

Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring

Frequently Asked Questions

How many trademarks does DONGKOO BIO & PHARMA CO., LTD. have?

DONGKOO BIO & PHARMA CO., LTD. has 3 U.S. trademarks filed with the USPTO. Of these, 1 registered.

What trademark classes does DONGKOO BIO & PHARMA CO., LTD. file in?

DONGKOO BIO & PHARMA CO., LTD. files trademarks across 2 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 3 (Cosmetics & Cleaning). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are DONGKOO BIO & PHARMA CO., LTD.'s most well-known trademarks?

DONGKOO BIO & PHARMA CO., LTD.'s registered trademark portfolio includes well-known marks such as CELL BLOOM. These are among 1 currently registered trademark in the portfolio.

What is DONGKOO BIO & PHARMA CO., LTD.'s trademark registration success rate?

DONGKOO BIO & PHARMA CO., LTD. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.